Survival after recurrence is poor for women with early-stage high-risk ovarian cancer: A Gynecologic Oncology Group study

被引:0
|
作者
Chan, J. K. [1 ]
Tech, D. [1 ]
Tian, C. [2 ]
Kapp, D. S. [3 ]
Monk, B. J. [4 ]
Herzog, T. [5 ]
Bell, J. [6 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] GOG Stat & Data Ctr, Buffalo, NY USA
[3] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[4] Univ Calif Irvine, Med Ctr, Irvine, CA 92717 USA
[5] Columbia Univ, New York, NY 10027 USA
[6] Ohio State Univ, Riverside Methodist Hosp, Columbus, OH 43210 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
63
引用
收藏
页码:S29 / S29
页数:1
相关论文
共 50 条
  • [1] Survival after recurrence in early-stage high-risk epithelial ovarian cancer: A Gynecologic Oncology Group study
    Chan, John K.
    Tian, Chunqiao
    Teoh, Deanna
    Monk, Bradley J.
    Herzog, Thomas
    Kapp, Daniel S.
    Bell, Jeffrey
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 307 - 311
  • [2] Symptoms of women with high-risk early-stage ovarian cancer: A Gynecologic Oncology Group study
    Kesterson, J.
    Chan, J. K.
    Tian, C.
    Monk, B. J.
    Bell, J. G.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S36 - S37
  • [3] Prognostic factors for high-risk early-stage epithelial ovarian cancer - A Gynecologic oncology group study
    Chan, John K.
    Tian, Chunqiao
    Monk, Bradley J.
    Herzog, Thomas
    Kapp, Daniel S.
    Bell, Jeffrey
    Young, Robert C.
    CANCER, 2008, 112 (10) : 2202 - 2210
  • [4] Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study
    Randall, Leslie M.
    Monk, Bradley J.
    Darcy, Kathleen M.
    Tian, Chunqiao
    Burger, Robert A.
    Liao, Shu-Yuan
    Peters, William A.
    Stock, Richard J.
    Fruehauf, John P.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (03) : 583 - 589
  • [5] Pretreatment CA-125 levels predict disease recurrence and overall survival in patients with high-risk early-stage ovarian cancer: A Gynecologic Oncology Group study
    Chan, J. K.
    Tian, C.
    Kesterson, J.
    Monk, B. J.
    Bell, J. G.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S20 - S21
  • [6] Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study
    Randall, L. M.
    Monk, B. J.
    Darcy, K. M.
    Tian, C.
    Burger, R. A.
    Liao, S.
    Peters, W. A.
    Stock, R. A.
    Fruehauf, J. P.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S22 - S22
  • [7] The pattern of CA-125 normalization during chemotherapy predicts for recurrence and survival in patients with high-risk early-stage ovarian cancer: A gynecologic oncology group study
    Chan, J.
    Tian, C.
    Yang, K.
    Kesterson, J.
    Kapp, D.
    Monk, B.
    Herzog, T.
    Bell, J.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 596 - 596
  • [8] Symptoms of Women With High-Risk Early-Stage Ovarian Cancer
    Chan, John K.
    Tian, Chunqiao
    Kesterson, Joshua P.
    Monk, Bradley J.
    Kapp, Daniel S.
    Davidson, Brittany
    Robertson, Sharon
    Copeland, Larry J.
    Walker, Joan L.
    Wenham, Robert M.
    Casablanca, Yovanni
    Spirtos, Nick M.
    Tewari, Krishnansu S.
    Bell, Jeffrey G.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2022, 77 (06) : 346 - 347
  • [9] Symptoms of Women With High-Risk Early-Stage Ovarian Cancer
    Chan, John K.
    Tian, Chunqiao
    Kesterson, Joshua P.
    Monk, Bradley J.
    Kapp, Daniel S.
    Davidson, Brittany
    Robertson, Sharon
    Copeland, Larry J.
    Walker, Joan L.
    Wenham, Robert M.
    Casablanca, Yovanni
    Spirtos, Nick M.
    Tewari, Krishnansu S.
    Bell, Jeffrey G.
    OBSTETRICS AND GYNECOLOGY, 2022, 139 (02): : 157 - 162
  • [10] Prognostic relevance of carbonic anhydrase IX in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study
    Liao, S.
    Darcy, K.
    Randall, L. M.
    Tian, C.
    Monk, B. J.
    Burger, R. A.
    Fruehauf, J. P.
    Barrett, R. J.
    Peters, W. A.
    Stock, R. J.
    Stanbridge, E.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S15 - S16